These drugs have demonstrated as much as 20% weight loss in recent studies, which is impressive and still less than triple agonists like retatrutide
GHK-Cu is studied for restoring that regenerative signal: smoother, firmer skin, better wound healing, and hair support
The side effects of B12 shots vs IV infusions differ primarily in injection site reactions and systemic risks
All participants in the orforglipron treatment arms started the study at a dose of orforglipron 1 mg once-daily and then increased the dose in a step-wise approach at four-week intervals until reaching their randomized maintenance dose of 12 mg (via steps at 1 mg, 3 mg and 6 mg) or 36 mg (via steps at 1 mg, 3 mg, 6 mg, 12 mg and 24 mg)
(PubMed) Davini P, Bigalli A, Lamanna F, Boem A